Immunosuppressive drugs in treatment of myasthenia gravis.
D000328:Adult; D001327:Autoimmune Diseases / Q000188:drug therapy*; D001379:Azathioprine / Q000627:therapeutic use; D001772:Blood Cell Count; D002066:Busulfan / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000188:drug therapy; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009157:Myasthenia Gravis / Q000188:drug therapy*
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D015122:Mercaptopurine; D002066:Busulfan; D001379:Azathioprine; D008558:Melphalan; D008727:Methotrexate